https://pamdx.com/news/ 2026-04-16T10:08:48+00:00 https://pamdx.com/news/new-compound-able-to-select-the-positive-effects-of-cortisol/ 2020-03-19T16:14:20+00:00 https://pamdx.com/news/pamstation12-demonstrated-at-miptech-2013-in-basel/ 2020-03-19T16:20:11+00:00 https://pamdx.com/news/cancer-research-in-zebrafish-with-the-pamgene-platform/ 2020-03-19T16:24:02+00:00 https://pamdx.com/news/promising-proof-of-concept-for-small-molecule-modality-to-treat-non-small-cell-lung-cancer/ 2020-03-19T16:25:17+00:00 https://pamdx.com/news/publication-on-a-detailed-analysis-of-a-new-kinase-inhibitor-for-acute-myeloid-leukemia/ 2020-03-19T16:26:24+00:00 https://pamdx.com/news/kinase-activity-profiling-tool-to-reveal-molecular-mechanisms-in-latent-hiv-1/ 2020-03-19T16:28:30+00:00 https://pamdx.com/wp-content/uploads/2020/03/large_0783055001431095980.png https://pamdx.com/news/10-year-kinase-inhibitor-research-in-a-nutshell/ 2020-03-19T16:37:24+00:00 https://pamdx.com/wp-content/uploads/2020/03/AACR-Whitepaper-Targets-graph.png https://pamdx.com/wp-content/uploads/2020/03/AACR-Whitepaper-PKI-Figure.png https://pamdx.com/news/acea-and-pamgene-join-forces-to-accelerate-kinase-research/ 2020-03-19T16:39:21+00:00 https://pamdx.com/wp-content/uploads/2020/03/ACEA-PamGene-Scratch-beneath-the-surface.png https://pamdx.com/news/at-aacr-kinase-activity-profiling-in-thyroid-and-renal-cancers-view-our-posters/ 2020-03-19T17:01:51+00:00 https://pamdx.com/wp-content/uploads/2020/03/large_0565118001429101264.png https://pamdx.com/wp-content/uploads/2020/03/large_0516072001429101892.png https://pamdx.com/wp-content/uploads/2020/03/Maria-Riet-Hilhorst-1.jpg https://pamdx.com/news/innovative-toxicology-collaboration-receives-major-funding/ 2020-03-19T17:44:46+00:00 https://pamdx.com/wp-content/uploads/2020/03/ZonMW-logo.gif https://pamdx.com/wp-content/uploads/2020/03/BMBF-logo-en.png https://pamdx.com/upload/image/Westerinck.png https://pamdx.com/news/prognostic-biomarkers-for-lung-cancer/ 2020-03-19T18:02:58+00:00 https://pamdx.com/wp-content/uploads/2020/03/Arni-S-Fig-WWW_350px.png https://pamdx.com/news/pamgene-posters-at-the-japanese-cancer-association-meeting/ 2020-03-23T07:48:46+00:00 https://pamdx.com/wp-content/uploads/2020/03/JCA-banner-www.jpg https://pamdx.com/wp-content/uploads/2020/03/large_0057279001506697278.jpg https://pamdx.com/wp-content/uploads/2020/03/large_0766608001506697390.jpg https://pamdx.com/wp-content/uploads/2020/03/large_0519637001506955677.jpg https://pamdx.com/news/spotlight-on-uveal-melanoma-the-um-cure-project/ 2020-03-23T07:59:19+00:00 https://pamdx.com/wp-content/uploads/2020/03/UM-cure2020-logo-www-1.png https://pamdx.com/wp-content/uploads/2020/03/UM-cure2020-tabs-1.png https://pamdx.com/wp-content/uploads/2020/03/PamGene-logo-1.jpg https://pamdx.com/wp-content/uploads/2020/03/Dianne-www.jpg https://pamdx.com/wp-content/uploads/2020/03/0614984001513265402.jpg https://pamdx.com/news/aacr-2018-follow-up/ 2020-03-23T08:07:33+00:00 https://pamdx.com/wp-content/uploads/2020/03/AACRSiteBanner.jpg https://pamdx.com/wp-content/uploads/2020/03/ben-abbott.jpeg https://pamdx.com/wp-content/uploads/2020/03/AACR-meet-the-4.jpg https://pamdx.com/news/at-asco-2018-predictive-biomarkers-for-immunotherapy-in-melanoma/ 2020-03-23T08:10:46+00:00 https://pamdx.com/wp-content/uploads/2020/03/large_0656071001528703645.jpg https://pamdx.com/news/iso-accreditation-for-the-diagnostic-assay-services-lab/ 2020-03-23T08:13:03+00:00 https://pamdx.com/wp-content/uploads/2020/03/ISO-Photo-www.jpg https://pamdx.com/wp-content/uploads/2020/03/blood-test-www.jpg https://pamdx.com/wp-content/uploads/2020/03/Blood-based-BM-www.png https://pamdx.com/news/download-the-aacr-2016-poster-on-the-clinical-efficacy-of-sunitinib/ 2020-06-10T14:33:12+00:00 https://pamdx.com/wp-content/uploads/2020/03/AACR-2016-logo.jpg https://pamdx.com/wp-content/uploads/2020/03/Gaelle-Noe.jpg https://pamdx.com/wp-content/uploads/2020/03/large_0956787001462277058-2.jpg https://pamdx.com/wp-content/uploads/2020/03/large_0885274001462277027-2.jpg https://pamdx.com/news/kinase-activity-decreases-with-alzheimers-disease-progression/ 2020-06-10T14:33:57+00:00 https://pamdx.com/wp-content/uploads/2020/03/Rosenberger-A-Fig.png https://pamdx.com/wp-content/uploads/2020/03/Andrea-Rosenberger-web.jpg https://pamdx.com/news/which-kinases-phosphorylate-peptides-on-the-pamchip/ 2020-06-10T14:35:18+00:00 https://pamdx.com/news/a-step-closer-to-realizing-personalized-lung-cancer-treatment/ 2020-06-10T14:35:26+00:00 https://pamdx.com/wp-content/uploads/2020/03/logo.svg https://pamdx.com/wp-content/uploads/2020/03/Triple-T-Logos-2.png https://pamdx.com/news/kinase-profiling-reveals-potential-target-in-prostate-cancer/ 2020-06-10T14:37:54+00:00 https://pamdx.com/wp-content/uploads/2020/03/large_0758135001431095581.png https://pamdx.com/news/the-identification-of-a-novel-fes-substrate/ 2020-07-24T08:23:04+00:00 https://pamdx.com/wp-content/uploads/2020/07/190709-FES-model-DEF-CMYK-expanded-003.jpg https://pamdx.com/wp-content/uploads/2020/07/Fig.-3C-1.jpg https://pamdx.com/news/computational-modeling-mini-symposium/ 2020-08-20T08:41:57+00:00 https://pamdx.com/wp-content/uploads/2020/08/Neurosciences-Symposium-Aug2020-viaAdobeSpark-web.jpg https://pamdx.com/news/pamgene-announces-presentation-of-positive-interim-results-for-its-blood-based-biomarker-test-to-predict-clinical-benefit-to-immune-checkpoint-inhibition-in-advanced-melanoma-and-nsclc-at-the-2020-eur/ 2020-09-03T12:26:36+00:00 https://pamdx.com/news/clinical-benefit-from-immune-checkpoint-inhibition-in-advanced-melanoma-and-nsclc-can-be-predicted-by-tyrosine-kinase-activity-profiling/ 2020-09-21T07:31:22+00:00 https://pamdx.com/news/university-toledo-turns-supercomputers-toward-cancer-research/ 2020-12-10T15:39:30+00:00 https://pamdx.com/news/kinases-and-cell-behavior-are-the-basis-of-my-work/ 2020-12-15T09:25:13+00:00 https://pamdx.com/news/journal-for-immunotherapy-of-cancer-publication-kinase-activity-profiling-as-a-predictor-of-response-to-ici-treatment/ 2021-01-08T10:07:18+00:00 https://pamdx.com/news/pamgene-shares-experience-on-biomarker-development-and-ici-therapy-response-prediction-at-cancer-bioinformatics-symposium/ 2021-01-28T10:56:53+00:00 https://pamdx.com/news/pamgene-receives-extended-iso-certificate/ 2021-06-03T11:02:28+00:00 https://pamdx.com/wp-content/uploads/2021/06/ISO-certificate-extension.jpg https://pamdx.com/news/learning-why-patients-display-poor-response-to-a-therapy-by-looking-at-deregulated-kinase-signaling/ 2021-06-15T12:47:34+00:00 https://pamdx.com/news/pamgene-novigenix-and-radboud-university-medical-center-secure-eurostars-funding-to-develop-a-multi-omic-predictive-immunotherapy-response-test-for-bladder-cancer-patients/ 2021-07-01T11:21:53+00:00 https://pamdx.com/news/pamgene-highlights-new-publications/ 2021-07-29T12:00:00+00:00 https://pamdx.com/news/pamgene-joins-the-8th-drug-discovery-strategic-summit/ 2021-11-04T11:15:38+00:00 https://pamdx.com/news/pamgene-and-sanquin-announce-extended-collaboration-to-enhance-development-of-pamgenes-predictive-immunotherapy-response-tests/ 2021-11-11T13:18:51+00:00 https://pamdx.com/news/jointly-advancing-mutation-independent-treatment-of-inherited-retinal-diseases/ 2021-12-09T14:22:07+00:00 https://pamdx.com/news/meet-our-specialists-unraveling-disease-mechanisms/ 2022-01-28T10:25:48+00:00 https://pamdx.com/wp-content/uploads/2021/11/Peter-LinkedIn-1.jpg https://pamdx.com/news/review-paper-the-past-and-current-trends-of-kinase-research-and-use-of-high-throughput-active-kinome-technologies/ 2022-02-10T15:31:36+00:00 https://pamdx.com/wp-content/uploads/2022/02/Active-kinome-profiling-technologies.jpg https://pamdx.com/news/meet-our-specialists-savithri-rangarajan/ 2022-03-10T07:33:44+00:00 https://pamdx.com/wp-content/uploads/2021/12/DSC0188.jpg https://pamdx.com/news/pamgene-receives-iso-134852016-from-dekra-certification-b-v-for-its-iopener-immunotherapy-response-prediction-test-devices/ 2022-04-07T10:30:34+00:00 https://pamdx.com/news/pamgene-alithea-chuv-secure-eurostars-funding-for-pan-cancer-blood-test/ 2023-04-03T11:37:33+00:00 https://pamdx.com/wp-content/uploads/2023/01/Logos-press-release.png https://pamdx.com/news/pamgene-ivdd-iopener-melanoma-test/ 2023-04-17T08:12:34+00:00 https://pamdx.com/news/pamgene-ivdd-iopener-nsclc-test/ 2023-04-17T08:13:36+00:00 https://pamdx.com/news/pamgene-iopener-nsclc-at-2022-esmo-immuno-oncology-meeting/ 2023-04-17T08:16:00+00:00 https://pamdx.com/news/pamgene-at-the-aacr-2023/ 2023-05-01T10:11:53+00:00 https://pamdx.com/wp-content/uploads/2023/04/AACR-image-www-e1682928603649.png https://pamdx.com/news/pamgene-awarded-7-5-million-funding-for-iopener-blood-test/ 2023-06-28T10:16:46+00:00 https://pamdx.com/news/pamgene-announces-7-poster-presentations-from-its-collaborators-at-the-aacr-meeting-in-san-diego-highlighting-innovative-applications-of-its-kinase-activity-profiling-platform/ 2024-03-21T05:40:38+00:00 https://pamdx.com/wp-content/uploads/2024/03/Exhibitor_Logo_2024.jpg https://pamdx.com/news/pamgene-presents-six-scientific-posters-at-aacr-2025/ 2025-04-23T07:26:01+00:00 https://pamdx.com/wp-content/uploads/2025/04/AAACR_2025_banner_downsized-1.png https://pamdx.com/wp-content/uploads/2025/04/AAACR_2025_banner_downsized-1.png https://pamdx.com/news/seven-key-kinase-activity-profiling-posters-at-the-aacr-2026/ 2026-04-14T15:22:53+00:00 https://pamdx.com/wp-content/uploads/2026/04/AACR-2026-Exhbitor-logo_PG.png https://pamdx.com/wp-content/uploads/2026/04/AACR-2026-Exhbitor-logo.png https://pamdx.com/news/pamdx-secures-e13-million-series-a-funding-to-advance-deployment-of-diagnostic-blood-tests-for-cancer-patients-treated-with-immunotherapy/ 2026-04-16T10:08:48+00:00